Skip to main content
. 2022 Dec 1;22:889. doi: 10.1186/s12884-022-05219-4

Table 2.

Clinical characteristics and laboratory biomarkers among the extended population

Variable Training cohort
(n = 1481)
Validation cohort
(n = 635)
p
Age (year) 30.0 (27.0–32.0) 29.0 (27.0–32.0) 0.438
Nulliparous, n (%) 0.147
 No 898 (60.6) 407 (64.1)
 Yes 583 (39.4) 228 (35.9)
History of GDM, n (%) 0.109
 No 1406 (94.9) 591 (93.1)
 Yes 75 (5.1) 44 (6.9)
History of macrosomia, n (%) 0.999
 No 1456 (98.3) 625 (98.4)
 Yes 25 (1.7) 10 (1.6)
History of abnormal pregnancy, n (%) 0.845
 No 1427 (96.4) 610 (96.1)
 Yes 54 (3.6) 25 (3.9)
Family history of DM, n (%) 0.911
 No 1458 (98.4) 624 (98.3)
 Yes 23 (1.6) 11 (1.7)
PCOS, n (%) 1.000
 No 1457 (98.4) 624 (98.3)
 Yes 24 (1.6) 11 (1.7)
Pre-pregnancy BMI (kg/m2) 20.5 (18.9–22.7) 20.6 (18.9–22.6) 0.631
WBC (109/L) 9.0 (7.8–10.4) 9.2 (7.8–10.5) 0.248
NEUT (%) 72.8 (68.7–76.5) 72.9 (68.9–76.6) 0.384
RBC (1012/L) 4.0 (3.8–4.3) 4.0 (3.8–4.3) 0.816
HGB (g/L) 121.1 (114.3–128.0) 121.0 (114.0–128.0) 0.950
HCT (%) 36.1 (34.0–38.0) 36.0 (33.8–37.9) 0.667
PLT (109/L) 235.0 (203.0–270.5) 233.0 (202.5–271.0) 0.826
MPV (fL) 9.1 (8.3–10.1) 9.2 (8.3–10.0) 0.494
ALT (U/L) 12.0 (9.0–19.0) 12.0 (9.0–17.0) 0.186
AST (U/L) 16.0 (13.9–20.0) 16.0 (13.5–19.0) 0.190
Creatinine (μmol/L) 46.6 (41.4–53.0) 46.0 (41.5– 52.5) 0.416
Uric acid (μmol/L) 237.0 (204.0–275.0) 235.0 (201.0–275.3) 0.793
FBG (mmol/L) 4.5 (4.2–4.9) 4.5 (4.2–4.9) 0.344
PT (s) 12.3 (10.9–12.8) 12.3 (10.1–12.8) 0.812
APTT (s) 32.6 (29.0–34.9) 32.3 (28.8–34.6) 0.213
FIB (mg/dL) 4.1 (3.7–4.5) 4.1 (3.7–4.5) 0.775
PAPP-A (MoM) 1.1 (0.7–1.6) 1.1 (0.7–1.6) 0.330

Abbreviations: GDM Gestational diabetes mellitus, DM Diabetes mellitus, PCOS Polycystic ovary syndrome, BMI Body mass index, WBC White blood cell count, NEUT Neutrophil percentage, RBC Red blood cell count, HGB Hemoglobin, HCT Hematocrit, PLT Platelet count, MPV Mean platelet volume, ALT Alanine aminotransferase, AST Aspartate aminotransferase, FBG Fasting blood glucose, PT Prothrombin time, APTT Activated partial thromboplastin time, FIB Fibrinogen, PAPP-A Pregnancy associated plasma protein A